📝 Hemo Organic Ltd — results explained
Quarter ended June 2026 (Q1 FY27)
Hemo Organic Ltd reported revenue of ₹0 crore for the quarter ended June 2026 (Q1 FY27), and down 100.0% sequentially over the March 2026 quarter.
The company reported a net loss of ₹0 crore, against a net loss of ₹0 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.20.
Full year and trailing twelve months
For the full year FY26, Hemo Organic Ltd posted revenue of ₹1 crore, a decline of 61.4% over FY25, with a net loss of ₹1 crore.
On a trailing-twelve-month (TTM) basis, revenue stands at ₹1 crore with a net loss of ₹1 crore.
Valuation snapshot
At the current price of ₹19.85, 524590 has a market capitalisation of ₹7 crore.
Within the Trading & Distributors industry, it is the 25th-largest of the 178 companies we track by market value.
Shareholding pattern
As of Jun 2026, promoters held 16.85%, public shareholders 83.16% of Hemo Organic Ltd.